Literature DB >> 6113182

Previous exposure to glucose enhances somatostatin secretion from the isolated perfused rat pancreas.

V Grill, M Rundfeldt, S Efendić.   

Abstract

Previous exposure to glucose enhances insulin and depresses glucagon secretion by the pancreas. We have investigated whether secretion of somatostatin is also influenced by a glucose priming effect. In perfused rat pancreas from 36 h fasted rats a 5 min pulse of arginine (8 mmol/l) rapidly elicited a peak of somatostatin release. A similar somatostatin response was evoked by a second, identical, pulse of arginine after perfusion with "basal" glucose (3.9 mmol/l) for 45 min. On the other hand when 27.7 mmol/l D-glucose, was administered for 20 min between arginine pulses, there was significant stimulation of somatostatin secretion. When arginine was re-introduced 15 min after the cessation of the pulse of elevated glucose the magnitude of the arginine-induced peak (min 0-2 of stimulation) was increased from 16.2 +/- 4.1 to 33.1 +/- 4.7 pg/2 min, p less than 0.01, relative to the first stimulation with arginine. None of these effects of glucose could be reproduced by D-galactose. The somatostatin response to arginine was higher in pancreata from fed than from 36 h fasted animals as was also basal release (22.8 +/- 5.0 vs 9.0 +/- 2.0 pg/min). In the fed state the response to the second pulse of arginine was however reduced by 50% after perfusion with "basal" glucose. This decrease in responsiveness was counteracted by perfusion with 27.7 mmol/l glucose for 20 min between the arginine pulses. It is concluded that previous exposure to an elevated concentration of glucose enhanced D-cell responsiveness to arginine in the fasted as well as the fed state.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113182     DOI: 10.1007/bf00253414

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  30 in total

1.  Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas.

Authors:  M P Dubois
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  The secretion of newly synthesized insulin in vitro.

Authors:  S L Howell; K W Taylor
Journal:  Biochem J       Date:  1967-03       Impact factor: 3.857

3.  Potentiation and inhibition of insulin release in man following priming with glucose and with arginine--effect of somatostatin.

Authors:  S Efendić; P E Lins; E Cerasi
Journal:  Acta Endocrinol (Copenh)       Date:  1979-02

4.  Tissue and serum somatostatin-like immunoreactivity in fed, 15-h-fasted, and 72-h-fasted rats.

Authors:  B Shapiro; M Berelowitz; B L Pimstone; S Kronheim; M Sheppard
Journal:  Diabetes       Date:  1979-03       Impact factor: 9.461

5.  [Further studies on the dynamic aspects of insulin release in vitro with evidence for a two-compartmental storage system].

Authors:  G M Grodsky; D Curry; H Landahl; L Bennett
Journal:  Acta Diabetol Lat       Date:  1969-09

6.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

Review 7.  Regulation of pancreatic insulin and glucagon secretion.

Authors:  J E Gerich; M A Charles; G M Grodsky
Journal:  Annu Rev Physiol       Date:  1976       Impact factor: 19.318

8.  The effect of fasting, diet, and actinomycin D on insulin secretion in the rat.

Authors:  N J Grey; S Goldring; D M Kipnis
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

9.  Starvation-induced changes of somatostatin, glucagon, and insulin secretion from the isolated perfused rat pancreas.

Authors:  S Seino; H Sakurai; Y Seino; K Tsuda; K Tanigawa; H Kuzuya; Y Goto; H Imura
Journal:  Diabetes       Date:  1980-04       Impact factor: 9.461

10.  Dynamic synthesis and release of insulin and proinsulin from perifused islets.

Authors:  H Sando; G M Grodsky
Journal:  Diabetes       Date:  1973-05       Impact factor: 9.461

View more
  7 in total

1.  B cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia.

Authors:  V Grill; M Westberg; C G Ostenson
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

2.  Dietary fatty acids modify insulin secretion of rat pancreatic islet cells in vitro.

Authors:  F J Tinahones; A Pareja; F J Soriguer; J M Gómez-Zumaquero; F Cardona; G Rojo-Martínez
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

3.  Difference in calcium dependency of insulin, glucagon and somatostatin secretion in response to glibenclamide in perfused rat pancreas.

Authors:  S Efendić; V Grill; A Nylén; C G Ostensson
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

4.  Loss of a priming effect of glucose on A and D cell secretion in perfused pancreases from alloxan-diabetic rats: role of insulin and alloxan.

Authors:  V Grill; S Efendić
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

5.  Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.

Authors:  Y P Zhou; V E Grill
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

6.  Diabetes reduces β-cell mitochondria and induces distinct morphological abnormalities, which are reproducible by high glucose in vitro with attendant dysfunction.

Authors:  Zuheng Ma; Tina Wirström; L A Håkan Borg; Gerd Larsson-Nyrén; Ingrid Hals; John Bondo-Hansen; Valdemar Grill; Anneli Björklund
Journal:  Islets       Date:  2012 May-Jun       Impact factor: 2.694

7.  Evidence for presence and functional effects of Kv1.1 channels in β-cells: general survey and results from mceph/mceph mice.

Authors:  Zuheng Ma; Catharina Lavebratt; Malin Almgren; Neil Portwood; Lars E Forsberg; Robert Bränström; Erik Berglund; Sture Falkmer; Frank Sundler; Nils Wierup; Anneli Björklund
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.